Xencor (XNCR) Cash from Operations Growth (1y) (2014 - 2026)
Xencor (XNCR) Cash from Operations Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Xencor | 1.49 Bn | 1.11 Bn | - | -316.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -316.94% |
| Dec 31, 2025 | -3.76% |
| Sep 30, 2025 | -9.51% |
| Jun 30, 2025 | 46.00% |
| Mar 31, 2025 | 71.47% |
| Dec 31, 2024 | -374.30% |
| Sep 30, 2024 | -3.16% |
| Jun 30, 2024 | -76.31% |
| Mar 31, 2024 | -85.73% |
| Dec 31, 2023 | 174.37% |
| Sep 30, 2023 | -2,235.70% |
| Jun 30, 2023 | -186.29% |
| Mar 31, 2023 | -626.47% |
| Dec 31, 2022 | -139.54% |
| Sep 30, 2022 | 97.01% |
| Jun 30, 2022 | 558.56% |
| Mar 31, 2022 | 119.41% |
| Dec 31, 2021 | 261.68% |
| Sep 30, 2021 | -909.39% |
| Jun 30, 2021 | 65.13% |